Author: marley.easterbrook

ICE-HBV would like to thank all chairs, presenters, panellists and attendees for the great experience of the 2020 Serum Biomarkers Workshop that was held on the 5th and 12th of October via Zoom.

Videos from all presentations and panel discussions are now available on the new ICE-HBV YouTube page.

Links to the abstracts, slides and videos of all presentations are also available on our Serum Biomarkers Workshop page here.

Thanks again to all who presented and attended for making it a very smoothly running and informative workshop.

“A Community Update on the Progress to a Hepatitis B Cure” was a Webinar hosted by the Hepatitis B Foundation and ICE-HBV. Presentation video and slides are available below.

The next webinar is on the 20th of October from 3-4pm Eastern Time to discuss the connection between Hepatitis B and Liver Cancer and strategies for preventing liver cancer for those with hepatitis B.

See a recording of the Presentation.

See Presentation slides.

The final programme for the ICE-HBV Serum Biomarkers Workshop to be held over Zoom on the 5th and 12th of October 2020 has been released. Please see the attached document for the full programme, objectives and background.

At the 2020 COLDA conference on Friday the 11th of September, Dr Massimo Levrero presented HBV Cure Science 101 on behalf of ICE-HBV.

ICE-HBV is celebrating World Hepatitis Day 2020 with this video on hepatitis B, please share to your networks.

ICE-HBV and Brown Dog Productions created this video in collaboration with the Doherty Institute, the Hepatitis B Foundation and the World Hepatitis Alliance, with support from its sponsors.

 

Despite the existence of an excellent preventative vaccine and antiviral therapies which effectively control the virus, chronic hepatitis B affects 257 million people and is one of the leading causes of death worldwide.  The global hepatitis B research community is working together with people living with hepatitis B to develop cures and many approaches are currently in early stage clinical trials.  Until these cures are available, it is imperative that people are tested and receive the life-saving antiviral treatment to control their HBV infection and prevent liver disease.

ICE-HBV encourages more people to get tested and treated for chronic HBV, and to let people living with HBV know that the global HBV research community is in their corner and is striving for a cure, so we can live a #hepfreefuture